For those new heres a look and background at how cutting edge this CDH-17 Car-T is and how respected it's 10 years in development is by the industry with a write up in Nature Cancer publication. Can you believe CHM only paid $350,000 upfront and in true Paul Hopper fashion with renumeration for the inventor and U Penn at other clinical trial and FDA milestones. Esspecially with Carl June the inventor of Car-T involved in it's development to where it is now.
Ann: Licenses viral vector technology from Penn for CDH17, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.045M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $22.28K | 6.311M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 78 | 84735861 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 86304338 | 23 |
View Market Depth
| Last trade - 14.27pm 25/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |